Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
318 participants
INTERVENTIONAL
2010-04-30
2013-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Rate and/or Presence of Dextrose on the Labor Course of Nulliparas
NCT01904617
Lactated Ringer's and Dextrose 5% vs Only Lactated Ringer's in Labor
NCT07124130
The Effects of Increased IV Hydration on Nulliparous Women Undergoing an Induction of Labor
NCT02989571
A Study on the Effects of Dextrose Solutions on the Course of Labor
NCT00569439
The Use of D5LR Versus LR for Induction of Labor and Time to Delivery in Multiparous and Primiparous Patient's With Favorable and Unfavorable Bishop's Scores
NCT03822052
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The primary research hypothesis is that intravenous hydration during labor with a glucose-containing fluid will lead to more efficient uterine contractility and will lead to a reduction of cesarean delivery. The primary outcome measure is the occurrence of a cesarean birth during the study period. The primary analysis will use an intent-to-treat approach to examine differences between the two IV fluid treatments in the proportion of deliveries requiring cesarean section.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
D5 Lactated Ringer's solution (D5LR)
IV fluid containing glucose administered throughout labor at an average infusion rate of 125 ml/hr.
D5 Lactated Ringer's Solution (D5LR)
D5LR IV fluid
Lactated Ringer's solution (LR)
Non-glucose IV fluid administered throughout labor at an average infusion rate of 125 ml/hr.
Lactated Ringer's Solution (LR)
LR IV fluid
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
D5 Lactated Ringer's Solution (D5LR)
D5LR IV fluid
Lactated Ringer's Solution (LR)
LR IV fluid
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. These women will be in good health and candidates for vaginal delivery.
Exclusion Criteria
2. Patients presenting for induction of labor or requiring induction upon admission.
3. Patients presenting for scheduled cesarean section.
4. Patients with any form of diabetes or glucose dysregulation condition.
5. Concurrent use of steroids.
6. Patients presenting in active labor with advanced cervical dilation (≥ 6 cm).
7. Subjects participating in another labor and delivery related clinical trial that conflicts with this trial (as determined by the site PI).
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Lehigh Valley Hospital
OTHER
The Reading Hospital and Medical Center
OTHER
St. Luke's Hospital, Pennsylvania
OTHER
Milton S. Hershey Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Richard S. Legro, M.D.
Professor, Obstetrics and Gynecology and Public Health Sciences
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Richard S Legro, M.D.
Role: STUDY_DIRECTOR
The Pennsylvania State University College of Medicine, Hershey, Pennsylvania, United States
John Smulian, M.D.
Role: PRINCIPAL_INVESTIGATOR
Lehigh Valley Hospital, Allentown, Pennsylvania, United States
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Lehigh Valley Hospital
Allentown, Pennsylvania, United States
St. Luke Hospital
Bethlehem, Pennsylvania, United States
The Penn State University
Hershey, Pennsylvania, United States
The Reading Hospital and Medical Center
Reading, Pennsylvania, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Dapuzzo-Argiriou LM, Smulian JC, Rochon ML, Galdi L, Kissling JM, Schnatz PF, Gonzalez Rios A, Airoldi J, Carrillo MA, Maines J, Kunselman AR, Repke J, Legro RS. A multi-center randomized trial of two different intravenous fluids during labor. J Matern Fetal Neonatal Med. 2016;29(2):191-6. doi: 10.3109/14767058.2014.998190. Epub 2015 Sep 4.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
32118
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.